Differential polymerase chain reaction with serial dilutions for quantification of MYCN gene amplification in neuroblastoma

Anticancer Research

Volumn 18, Issue 2 A, 1998, Pages 1211-1215

  Gallego, Soledad ^a,b   Reventos, Jaume ^a   De Toledo, José Sanchez ^a   Munell, Francina ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

Differential PCR; MYCN amplification; Neuroblastoma

Indexed keywords

DNA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; EARLY DIAGNOSIS; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; INFANT; NEUROBLASTOMA; ONCOGENE MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TECHNIQUE;

BLOTTING, SOUTHERN; GENE DOSAGE; GENES, MYC; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; NEUROBLASTOMA; POLYMERASE CHAIN REACTION;

EID: 0031866146     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Brodeur GM: Molecular basis for heterogeneity in human neuroblastoma. Eur J Cancer 31A: 505-510, 1995.
2. Brodeur GM, Azar C, Brother M, Hiemstra J, Kaufman B, Marshall H, Moley J, Nakagawara A, Saylors R, Scavarda N, Schneider S, Wasson J, White P, Seeger R, Look T and Castleberry R: Neuroblastoma: Effect of genetic factors on prognosis and treatment. Cancer 70: 1685-1694, 1992.
3. Shimada H, Stram DO, Chatten J, Joshi V, Hachitanda Y,Brodeur GM, Lukens JN, Matthay KK and Seeger RC: Identification of subsets of neuroblastomas by combined histopathologic andN-myc analysis. JNatl Cancer Inst 87: 1470-1476, 1995.
4. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY and Hammond D: Association of multiple copies of the N-myc oncogene with rapid progression in neuroblastomas. N Engl J Med 313: 1111 - 1116, 1985.
5. Ambros PF, Ambros IM, Ladenstein R and Gadner H: Neuroblastoma: Impact of biological characteristics on treatment strategies. Onkologie 18: 548-555, 1995.
6. Muraji T, Okamoto E, Fujimoto J, Suita S and Nakagawara A: Combined determination of N-myc oncogene amplification and DNA ploidy in neuroblastoma: Complementary prognostic indicators. Cancer 72: 2763-2768, 1993.
7. Cohn S, Look T, Joshi V, Holbrook T, Salwen H, Chagnovich D, Chesler L, Rowe S, Valentine M, Komuro H, Castleberry RP, Bowman LC, Rao PV, Seeger RC and Brodeur GM: Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: A Pediatric Oncology Group study. Cancer Res 55: 721-726, 1995.
8. Frye RA, Benz CA and Liu E: Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene 4: 1153-1157, 1989.
9. Gilbert J, Norris MD, Haber M, Kavallaris M, Marshall GM and Stewart BW: Determination of N-myc gene amplification in neuroblastomas by differential polymerase chain reaction. Mol Cell Prob 7: 227-234, 1993.
10. Sambrook J, Fritsch EF and Maniatis T: "Molecular cloning", 2nd ed. Cold Spring Harbor Laboratory, NY: Cold Spring Harbor Press. (1989).
11. Ibson JM and Rabbitts PH: Sequence of a germ line N-myc gene and amplification as a mechanism of activation. Oncogene 2: 399-402, 1988.
12. Suita S, Zaizen Y, Kaneko M, Uchino J, Takeda T, Iwafuchi M, Utsumi J, Takahashi H, Yokoyama J, Nishihira H, Okada A, Kawa K, Nagahara N, Yano H and Tsuchida Y: What is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report of the Japanese Study Group for the treatment of advanced neuroblastoma. J Pediatr Surg 29: 746-750, 1994.
13. Niethammer D and Handgretinger R: Clinical strategies for the treatment of neuroblastoma.Eur J Cancer 31A: 568-571, 1995.
14. Misra DN, Dickman PS and Yunis EJ: Fluorescence in situ hybridization (FISH) detection of MYCN oncogene amplification in neuroblastoma using paraffin-embedded tissues. Diagn Mol Pathol 4: 128-135, 1995.
15. Avet-Loiseau H, Vernuat A, Benard J, Leibovitch M, Hartmann O and Bernheim A: Morphologic and molecular cytogenetics in neuroblastoma. Cancer 75: 1694-1699, 1995.
16. Esteller M, Garcia A, Martinez JM, Cabero A and Reventes J: Detection of c-erbB- 2/neu and fibroblast growth factor-3/INT-2 but not Epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction. Cancer 75: 2139-2146, 1995.
17. Crabbe DCG, Peters J and Seeger RC: Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction. Diagn Mol Pathol 1: 229-234, 1992.
18. Waha A, Rollbrocker B, Wiestler OD and von Deimling A: A polymerase chain reaction-based assay for the rapid detection of gene amplification in human tumors. Diagn Mol Pathol 5: 147-150, 1996.